FDA moves to ban phenylephrine, found in dozens of popular cold medications, after research shows it performs no better than ...

trigger mild cold-like symptoms. But in infants and seniors, these viruses can ... New Roles in Infectious Process for Molecule That Inhibits Flu Nov. 14, 2024 — Researchers have identified new ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and ...

Feb. 26, 2025 — Pre-existing immunity against seasonal H1N1 flu might help explain why most reported human cases of H5N1 bird flu in the U.S. have not resulted in lethal ... Backyard Poultry ...

Cold and flu season is in full swing right now. It is super easy to get sick with all of these ailments, but if students are ...

One of those struck down is Professor Ron Eccles, chairman of the Cold and Flu Council and director of the Common Cold Centre at Cardiff University. Blaming his wife for passing on the virus - the ...

Zoetis received conditional USDA approval for an avian flu vaccine. Major poultry and dairy organizations back vaccine use to control the virus. The Trump administration is rolling out a new ...

Have a Turkish bath: The flu virus can linger in the body for five to six weeks after the symptoms have cleared. According to Professor Ron Eccles, a specialist in cold and flu research ...

Traveling in cold weather conditions can be life threatening. The information provided here is designed for educational use only and is not a substitute for specific training or experience. Princeton ...

The 25,000-subject study is testing a nucleoside-modified mRNA (modRNA), quadrivalent vaccine that is targeted against four strains of the flu virus that the World Health Organization (WHO ...

The slip-up hands an opportunity for mRNA vaccine rival Moderna to build a lead in the combined COVID-19/flu vaccine category. In June, Moderna said its candidate met its objectives in a phase 3 ...